OVERVIEW

[Diabetes Trends] Considerations for Advancing Treatment After Metformin is organized by Horizon CME and will be held from Dec 20, 2018 - Dec 20, 2019. This Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credit(s)™.

Target Audience:
The target audience for this educational activity is primary care physicians (internal medicine, family practice MD/DOs), nurse practitioners (NPs), and physician assistants (PAs) who practice in a primary care setting.

Course Overview:
This webcast will outline current guideline recommendations for treatment intensification in patients not achieving glycemic control on metformin, discuss the clinical and patient-specific considerations for treatment selection in patients requiring treatment intensification and assess the benefits and risks of newer fixed-dose oral combination therapies for the treatment of type 2 diabetes.

Additional details will be posted as soon as they are available.